Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-107798
Filing Date
2024-09-18
Accepted
2024-09-18 16:15:17
Documents
1
Period of Report
2024-09-18

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 12747
  Complete submission text file 0000950170-24-107798.txt   14470
Mailing Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709
Business Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Issuer) CIK: 0001560241 (see all company filings)

EIN.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O G1 THERAPEUTICS, 700 PARK OFFICES DR SUITE 200, P.O. BOX 110341 RESEARCH TRIANGLE PARK NC 27709
Business Address
Flowers Cynthia Louise (Reporting) CIK: 0001741455 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38096 | Film No.: 241307710